Risk and special populations
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
which risk factors make covid worse/better/no effect
RSP - identifying risk factors
which characteristics has covid in a diseased patient with underlying disorder/state
Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak
HIV other pharmacology
Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic
indoor livin ppl
Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32222253 2020. COVID-19: lessons from the Italian reproductive medical experience
32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients
32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?
32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?
32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
32147409 ä. Are children less susceptible to COVID-19?
32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
| 32335512 2020. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs |
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases
32224304 2020. COVID-19 infection in children
32332856 ä. COVID-19 in persons with haematological cancers
32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32265531 ä. COVID-19 and cancer: what we know so far
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32265531 ä. COVID-19 and cancer: what we know so far
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32372803 2020. Children and covid-19
32243722 2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection
32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19
32212348 2020. Why is COVID-19 so mild in children?
32339307 2020. Additional hypotheses about why COVID-19 is milder in children than adults
32279351 2020. We urgently need guidelines for managing COVID-19 in children with comorbidities
32311145 2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience
32243621 2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
32267016 2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)
32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease
32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend
32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR
32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19
32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic
32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS
32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab
32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19
32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32286926 2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
32319118 2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
32345686 2020. Vulnerable Youth and the COVID-19 Pandemic
32317311 2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children
32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
32348044 2020. L'hematologie au temps du COVID-19
32348042 2020. Infection a SARS-CoV-2 et transplantation d'organes solides
32387456 ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
32387167 ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
32376969 ä. COVID-19 outcomes in patients with hematologic disease
32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank
32388171 2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32376043 ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak
32376098 ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
32388230 2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
32389426 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...
32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection
32387757 2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?
